Carl Zeiss Meditec (AFX.DE) stock price, revenue, and financials

Carl Zeiss Meditec market cap is €15.8 b, and annual revenue was €1.28 b in FY 2018

€15.8 B

AFX.DE Mkt cap, 10-Nov-2021

€667.2 M

Carl Zeiss Meditec Revenue H1, 2019
Carl Zeiss Meditec Gross profit (H1, 2019)373 M
Carl Zeiss Meditec Gross profit margin (H1, 2019), %55.9%
Carl Zeiss Meditec Net income (H1, 2019)58.9 M
Carl Zeiss Meditec EBITDA (H1, 2019)133.3 M
Carl Zeiss Meditec EBIT (H1, 2019)110.4 M
Carl Zeiss Meditec Cash, 31-Mar-201910.4 M
Carl Zeiss Meditec EV16 B
Get notified regarding key financial metrics and revenue changes at Carl Zeiss MeditecLearn more
Banner background

Carl Zeiss Meditec Revenue

Carl Zeiss Meditec revenue was €1.28 b in FY, 2018 which is a 7.6% year over year increase from the previous period.

Embed Graph

Carl Zeiss Meditec Revenue Breakdown

Embed Graph

Carl Zeiss Meditec revenue breakdown by business segment: 72.9% from Ophthalmic Devices and 27.1% from Microsurgery

Carl Zeiss Meditec revenue breakdown by geographic segment: 9.0% from Europe, 51.2% from Germany, 31.7% from USA and 8.1% from Japan

Carl Zeiss Meditec Income Statement

Annual

EURFY, 2016FY, 2017FY, 2018

Revenue

1.1b1.2b1.3b

Revenue growth, %

9%8%

Cost of goods sold

508.8m533.2m570.5m

Gross profit

579.5m656.7m710.4m

Gross profit Margin, %

53%55%55%

Sales and marketing expense

255.3m289.6m303.8m

R&D expense

123.4m145.8m159.6m

General and administrative expense

46.5m48.1m49.8m

Operating expense total

425.2m475.9m513.3m

Depreciation and amortization

20.2m24.2m31.3m

EBITDA

174.6m205.1m228.4m

EBITDA margin, %

16%17%18%

EBIT

154.3m180.8m197.1m

EBIT margin, %

14%15%15%

Interest expense

2.2m1.7m2.1m

Interest income

1.1m937.0k977.0k

Pre tax profit

142.0m188.6m179.2m

Income tax expense

42.0m52.8m53.0m

Net Income

100.0m135.8m126.2m

EPS

1.21.61.4

Half Year

EURH1, 2017H1, 2018H1, 2019

Revenue

587.5m613.7m667.2m

Cost of goods sold

265.3m278.4m294.2m

Gross profit

322.2m335.3m373.0m

Gross profit Margin, %

55%55%56%

Sales and marketing expense

140.9m142.4m156.1m

R&D expense

69.9m80.0m78.5m

General and administrative expense

24.1m24.6m28.0m

Operating expense total

227.1m247.0m262.6m

Depreciation and amortization

11.2m13.1m22.9m

EBITDA

106.3m101.3m133.3m

EBITDA margin, %

18%17%20%

EBIT

95.1m88.2m110.4m

EBIT margin, %

16%14%17%

Interest expense

722.0k1.2m3.9m

Interest income

491.0k379.0k694.0k

Pre tax profit

93.0m83.9m88.0m

Income tax expense

29.1m27.7m29.1m

Net Income

63.8m56.3m58.9m

Carl Zeiss Meditec Balance Sheet

Annual

EURFY, 2016FY, 2017FY, 2018

Cash

8.7m3.9m6.7m

Accounts Receivable

189.2m195.3m192.3m

Prepaid Expenses

8.9m8.2m8.1m

Inventories

208.3m234.3m248.1m

Current Assets

858.8m1.2b1.3b

PP&E

64.5m58.7m62.6m

Goodwill

164.6m174.3m185.6m

Total Assets

1.2b1.6b1.7b

Accounts Payable

57.1m64.9m67.4m

Short-term debt

25.6m8.6m19.2m

Current Liabilities

285.9m316.1m280.2m

Long-term debt

7.7m3.6m7.3m

Non-Current Liabilities

110.7m65.3m67.2m

Total Debt

33.3m12.1m26.6m

Common Stock

81.3m89.4m89.4m

Additional Paid-in Capital

313.9m620.1m620.1m

Retained Earnings

458.3m555.2m632.5m

Total Equity

851.2m1.2b1.3b

Debt to Equity Ratio

0 x0 x0 x

Debt to Assets Ratio

0 x0 x0 x

Financial Leverage

1.5 x1.3 x1.3 x

Half Year

EURH1, 2017H1, 2018H1, 2019

Cash

9.3m5.7m10.4m

Accounts Receivable

180.9m179.7m173.8m

Inventories

229.4m247.5m270.7m

Current Assets

1.2b1.2b1.2b

PP&E

64.5m55.7m116.1m

Goodwill

166.4m170.9m388.7m

Total Assets

1.6b1.6b1.8b

Accounts Payable

55.2m53.1m75.3m

Short-term debt

20.2m11.6m33.6m

Current Liabilities

288.3m254.6m285.4m

Long-term debt

5.6m1.9m158.7m

Non-Current Liabilities

83.4m66.8m234.7m

Total Debt

25.8m13.4m192.3m

Common Stock

89.4m89.4m89.4m

Additional Paid-in Capital

620.1m620.1m620.1m

Retained Earnings

520.1m611.2m643.0m

Total Equity

1.3b1.3b1.3b

Debt to Equity Ratio

0 x0 x0.1 x

Debt to Assets Ratio

0 x0 x0.1 x

Financial Leverage

1.3 x1.3 x1.4 x

Carl Zeiss Meditec Cash Flow

Annual

EURFY, 2016FY, 2017FY, 2018

Net Income

100.0m135.8m126.2m

Depreciation and Amortization

20.2m24.2m31.3m

Accounts Receivable

(2.6m)(49.0m)(113.0k)

Inventories

(15.2m)(33.4m)(11.8m)

Accounts Payable

19.2m15.3m921.0k

Cash From Operating Activities

111.8m37.7m187.2m

Purchases of PP&E

(12.8m)(13.7m)(16.5m)

Cash From Investing Activities

77.3m(55.9m)(28.9m)

Short-term Borrowings

(32.0k)219.0k(102.0k)

Long-term Borrowings

(3.2m)311.7m(3.4m)

Dividends Paid

(30.9m)(63.8m)(57.7m)

Cash From Financing Activities

(195.0m)14.5m(157.2m)

Net Change in Cash

(4.3m)(4.8m)2.8m

Interest Paid

1.6m1.6m1.9m

Income Taxes Paid

43.0m63.4m50.9m

Half Year

EURH1, 2017H1, 2018H1, 2019

Net Income

63.8m56.3m58.9m

Depreciation and Amortization

11.2m13.1m22.9m

Accounts Receivable

(24.4m)(14.8m)16.9m

Inventories

(18.6m)(18.9m)(17.6m)

Accounts Payable

(92.0k)(14.1m)3.5m

Cash From Operating Activities

16.5m34.4m89.1m

Purchases of PP&E

(6.0m)(6.7m)(10.1m)

Cash From Investing Activities

(20.1m)(8.9m)(122.9m)

Short-term Borrowings

(193.0k)(72.0k)(207.0k)

Long-term Borrowings

313.2m(1.6m)(6.5m)

Dividends Paid

(5.6m)(49.2m)

Cash From Financing Activities

4.7m(23.6m)37.1m

Net Change in Cash

598.0k1.7m3.8m

Interest Paid

707.0k1.2m948.0k

Income Taxes Paid

33.9m26.2m39.5m

Carl Zeiss Meditec Ratios

EURFY, 2016

EV/EBITDA

16.1 x

EV/EBIT

18.2 x

EV/CFO

25.2 x

Revenue/Employee

374.0k

Financial Leverage

1.5 x

P/E Ratio

28.0

Carl Zeiss Meditec Operating Metrics

FY, 2016H1, 2017FY, 2017H1, 2018FY, 2018H1, 2019

Order Volume

€162.7 m€175.7 m€165.3 m€155.8 m€152.9 m€151.8 m

Patent Families

800850850

Trademarks and Trademark Applications

630610530

R&D Centers

252525

Sales and Service Locations

505060

Eyes Treated to Date, SMILE

600 k1 m1.5 m